Example: Heart Attack

Search clinical trials for: Interleukin-2

Total 178 results

NCT02964078

Active, not recruiting

Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

Conditions: Kidney Cancer
NCT02027935

Active, not recruiting

Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4

Conditions: Melanoma
NCT02989714

Completed

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

Conditions: Renal Cell Carcinoma
NCT04055623

Active, not recruiting

T-regulatory Cells in ALS

Conditions: ALS (Amyotrophic Lateral Sclerosis)
NCT02414945

Active, not recruiting

TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients

Conditions: Pleural Mesothelioma
NCT04052334

Recruiting

Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma

Conditions: Sarcoma
NCT04812470

Not yet recruiting

Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases

Conditions: Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma
NCT04562129

Recruiting

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Conditions: Melanoma Stage III, Melanoma Stage IV, Inoperable Disease
NCT04643574

Recruiting

NeoTIL in Advanced Solid Tumors

Conditions: Solid Tumor, Adult
NCT03287674

Completed

TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer

Conditions: Metastatic Ovarian Cancer
NCT03992326

Terminated

Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

Conditions: Solid Tumor, Adult
NCT03213964

Completed

Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int

Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
NCT04735471

Recruiting

A Study of ADI-001 in B Cell Malignancies

Conditions: Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma, Lymphoma, Burkitt, Mediastinal Lymphoma, Diffuse Large B Cell Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse
NCT01662804

Active, not recruiting

Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors

Conditions: Neuroblastoma
NCT04673617

Recruiting

AB-101 as Monotherapy and In Combination With Rituximab in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Conditions: Non Hodgkin Lymphoma
NCT03215810

Active, not recruiting

Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

Conditions: Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Squamous Cell Carcinoma, Advanced NSCLC, Adenosquamous Carcinoma, Adenocarcinomas
NCT03546426

Recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Conditions: Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer, Progressive Disease
NCT01857934

Active, not recruiting

Therapy for Children With Advanced Stage Neuroblastoma

Conditions: Neuroblastoma
NCT04766307

Recruiting

A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Conditions: Tuberculosis, Pulmonary
NCT04354025

Not yet recruiting

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML

Conditions: Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia
NCT04023149

Recruiting

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT02340676

Active, not recruiting

A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD

Conditions: Chronic Graft-versus-host-disease
NCT01366092

Active, not recruiting

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Conditions: Chronic Graft-versus-host Disease
NCT03928275

Not yet recruiting

The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma

Conditions: Cutaneous Metastatic Melanoma
NCT04263831

Not yet recruiting

LOW DOSE IL-2 FOR THE TREATMENT OF CROHN'S DISEASE

Conditions: Crohn Disease